Efficacy of Ustekinumab for Active Perianal Fistulizing Crohn Disease: A Double-Center Cohort Study

Mohamed Attauabi; Johan Burisch; Jakob Benedict Seidelin

doi:10.1093/ibd/izaa297

Efficacy of Ustekinumab for Active Perianal Fistulizing Crohn Disease: A Double-Center Cohort Study

Mohamed Attauabi, Johan Burisch, Jakob Benedict Seidelin

12 Citations (Scopus)

Original language	English
Article number	izaa297
Journal	Inflammatory Bowel Diseases
Volume	27
Issue number	3
Pages (from-to)	e37-e38
Number of pages	2
ISSN	1078-0998
DOIs	https://doi.org/10.1093/ibd/izaa297
Publication status	Published - Mar 2021

Keywords

perianal fistulizing Crohn disease
ustekinumab

Access to Document

10.1093/ibd/izaa297

Cite this

@article{8d30caaea00b498cb5580b42cec3ce37,

title = "Efficacy of Ustekinumab for Active Perianal Fistulizing Crohn Disease: A Double-Center Cohort Study",

keywords = "perianal fistulizing Crohn disease, ustekinumab",

author = "Mohamed Attauabi and Johan Burisch and Seidelin, {Jakob Benedict}",

year = "2021",

month = mar,

doi = "10.1093/ibd/izaa297",

language = "English",

volume = "27",

pages = "e37--e38",

journal = "Inflammatory Bowel Diseases",

issn = "1078-0998",

publisher = "John/Wiley & Sons, Inc",

number = "3",

}

TY - JOUR

T1 - Efficacy of Ustekinumab for Active Perianal Fistulizing Crohn Disease

T2 - A Double-Center Cohort Study

AU - Attauabi, Mohamed

AU - Burisch, Johan

AU - Seidelin, Jakob Benedict

PY - 2021/3

Y1 - 2021/3

KW - perianal fistulizing Crohn disease

KW - ustekinumab

UR - http://www.scopus.com/inward/record.url?scp=85097191469&partnerID=8YFLogxK

U2 - 10.1093/ibd/izaa297

DO - 10.1093/ibd/izaa297

M3 - Letter

C2 - 33200769

SN - 1078-0998

VL - 27

SP - e37-e38

JO - Inflammatory Bowel Diseases

JF - Inflammatory Bowel Diseases

IS - 3

M1 - izaa297

ER -

Efficacy of Ustekinumab for Active Perianal Fistulizing Crohn Disease: A Double-Center Cohort Study

Keywords

Access to Document

Other files and links

Cite this